Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2,4 Diaminotoluene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103804202A details a safer catalytic hydrogenation route for diaminotoluene, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN104193624A reveals safer supported nickel catalyst for diaminotoluene. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Novel crystallization method separates diaminotoluene isomers efficiently. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.